Full-Time
Confirmed live in the last 24 hours
Provides tools for life sciences research
$24 - $26/hr
Junior, Mid
San Diego, CA, USA
Upload your resume to see how it matches 15 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
Maravai LifeSciences provides tools and services to support life sciences research and bioproduction. The company focuses on helping scientists make significant scientific advancements, especially in genomics, tumor pathology, and biotherapeutics. Maravai LifeSciences works by investing in and supporting life science companies, providing them with expertise, funding, and systems to help them grow. Their revenue comes from offering specialized products and services, such as oligonucleotide synthesis for PCR, NGS, and gene editing, as well as immunohistochemistry for cancer research. Unlike many competitors, Maravai LifeSciences emphasizes nurturing entrepreneurial companies, which allows them to better serve academic institutions, biotechnology firms, and pharmaceutical companies. The goal of Maravai LifeSciences is to facilitate research and development that improves human health.
Company Size
51-200
Company Stage
IPO
Headquarters
San Diego, California
Founded
2014
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Company Equity
Fertility Treatment Support
Family Planning Benefits
401(k) Retirement Plan
Paid Vacation
MRVI INVESTOR ALERT: Maravai LifeSciences Holdings, Inc. investors with substantial losses have opportunity to lead Class Action lawsuit.
SAN DIEGO, March 1, 2025 /PRNewswire/ - The law firm of Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) focused on whether the company and certain of its top executives made false and/or misleading statements and/or failed to disclose material information to investors.
SAN DIEGO - Maravai LifeSciences, Inc. (NASDAQ: MRVI), a $796 million market cap company known for supplying life science reagents and services, has announced the acquisition of intellectual property and assets from Molecular Assemblies, Inc.
Maravai LifeSciences appoints R. Andrew Eckert as Chairman of the Board of Directors.
More recently, Maravai acquired the molecular biology enzyme provider Alphazyme, LLC, in 2022.